Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.
作者信息
Weiskopf Richard B
机构信息
Research & Development, Novo Nordisk A/S, Bagsvaerd, Denmark.
出版信息
Acad Emerg Med. 2007 Apr;14(4):e71-3. doi: 10.1197/j.aem.2006.12.001. Epub 2007 Feb 25.
PMID:17322571
Abstract
摘要
Zotero 插件